Targeting Oncology

In the search to improve cancer outcomes, each promising advance across the biopharmaceutical frontier comes with challenges as unique as the specific molecular pathway and individual genetic profile it targets. Because oncology is not a one-size-fits-all discipline, Quintiles provides fully integrated clinical, commercial, consulting and capital solutions at every stage of a product's lifecycle so customers can stay focused without missing opportunities.

Despite dramatic advances — today, two-thirds of patients survive 5 years after diagnosis compared to just half of patients 40 years ago, and mortality rates have dropped 15% since 1990 — the WHO predicts new cancer cases will soar by 50% globally between 2000 and 2010. Against the complex backdrop of escalating risk, spiraling development costs averaging $1 billion dollars, and success rates as low as 5% moving from Phase 1 to NDA, we share your sense of urgency to develop new and better therapies.

We also share the renewed sense of optimism emerging among our customers, because we're seizing more opportunities for success than ever before in the New Health. We're part of the patient-centric progress being made in oncology treatments.

Like you, we understand that oncology drug development demands both a deeper level of scientific expertise and a broader, more holistic approach to global regulatory approvals and market access. From portfolio strategy to trial design and execution; to regulatory submission and post-marketing requirements, you need an ally with the know-how to navigate every stage of oncology product development to help you minimize risk and seize opportunity. We're here to help.

The commercial success of a therapy hinges upon more than developing and executing the clinical trial. At Quintiles, our approach incorporates not just clinical, but also commercial, consulting and capital solutions. We're the only biopharmaceutical services company that can offer this integrated approach to oncology drug development and commercialization, providing data-driven insights that spur action, overcome complexities and streamline processes, and help drive better outcomes.